RELATIONSHIP BETWEEN ANEMIA AND SOME CLINICAL FEATURES IN PATIENTS AFTER KIDNEY TRANSPLANTATION AT MILITARY HOSPITAL 103
Main Article Content
Abstract
(1) Objective: This study aims to delineate the characteristics of anemia in patients beyond 12 months post-kidney transplant under treatment surveillance at Military Hospital 103 and analyze the correlation between the degree of anemia and specific clinical characteristics in these individuals. (2) Method: A cross-sectional descriptive study involving 123 post-kidney transplant patients, monitored for over 12 months from October 2022 to May 2023. (3) Results: The mean age of participants was 41.93 ± 11.42 years, with a male/female ratio of 1.2/1. Notably, 13.8% and 25.2% of patients were transplanted preemptively before dialysis and maintained follow-up for more than 10 years post-transplant, respectively. The majority of patients (52.8%) exhibited mild anemia, characterized by normal-sized red blood cells (72.4%) and isochromic features (54.5%). The degree of anemia demonstrated statistically significant differences among BMI groups and blood pressure control (p<0.05). A low BMI below 18.5 emerged as an independent risk factor associated with the degree of anemia in patients after kidney transplantation, with an odds ratio of 3.633 and p < 0.05. (4) Conclusion: Anemia remains a prevalent issue in post-kidney transplant patients, primarily presenting as mild in severity, characterized by normochromic, normocytic features. The study highlights the association between undercontrolled hypertension and post-transplant anemia, emphasizing that a low BMI below 18.5 independently contributes as a significant risk factor for severe anemia.
Article Details
Keywords
Chronic kidney disease, Post-transplantation, Anemia
References
2. Hội ghép tạng Việt nam. Hướng dẫn ghép thận Việt nam. Nhà xuất bản Y học. 2017; 2:283-293.
3. WHO G. WHO methods and data sources for global burden of disease estimates 2000-2011. Geneva: Department of Health Statistics and Information Systems. 2013.
4. Kasiske BL, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000; 11(15):S1-86.
5. Molnar MZ, Mucsi I, Macdougall IC, et al. Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clinical Practice. 2011; 117(2):c127-c134.
6. Schechter A, Gafter-Gvili A, Shepshelovich D, et al. Post renal transplant anemia: Severity, causes and their association with graft and patient survival. BMC Nephrology. 2019; 220(1): 1-11.
7. Rosales Morales KB, Pérez RE, Cancino López JD, et al. Anemia and erythrocytes: Behavior and prevalence 1 year after kidney transplant. Transplant Proc. 2020; 252(4):1169-1172.
8. Beshara S, Birgegard G, Goch J, et al. Assessment of erythropoiesis following renal transplantation. Eur J Haematol. 1997; 58(3):167-173.
9. Taber DJ, Meadows HB, Pilch NA, et al. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013; 27(2):2.
10. Kim CS, Oh TR, Suh SH, et al. Uncontrolled hypertension is associated with increased risk of graft failure in kidney transplant recipients: A nationwide population-based study. Front. Cardiovasc. Med. 2023; 10:1185001.
11. Winkelmayer WC, Kewalramani R, Rutstein M, et al. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004; 15:1347-1352.
12. Shiferaw WS, TY Akalu, and YA Aynalem. Risk factors for anemia in patients with chronic renal failure: A systematic review and meta-analysis. Ethiop J Health Sci. 2020; 30(5):829-842.
13. Gafter-Gvili A, et al. Posttransplantation anemia in kidney transplant recipients: A retrospective cohort study. Medicine (Baltimore). 2017; 96(32):e7735.
14. Friend P, Russ G, Oberbauer R, et al. Incidence of anemia in sirolimus-treated renal transplant recipients: The importance of preserving renal function. Transpl Int. 2007; 220:754-760.